These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3850645)

  • 1. Complement factor D in serum. An indicator of glomerular filtration rate in chronic inflammatory arthritis.
    Sturfelt G; Keller C; Truedsson L; Thysell H
    Scand J Rheumatol; 1985; 14(3):315-7. PubMed ID: 3850645
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum level of complement factor D in systemic lupus erythematosus--an indicator of glomerular filtration rate.
    Sturfelt G; Truedsson L; Thysell H; Björck L
    Acta Med Scand; 1984; 216(2):171-7. PubMed ID: 6388250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate.
    Grubb A; Simonsen O; Sturfelt G; Truedsson L; Thysell H
    Acta Med Scand; 1985; 218(5):499-503. PubMed ID: 3911736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation products and factors influencing phagocyte migration in synovial fluids from children with chronic arthritis.
    Miller JJ; Olds LC; Huene DB
    Clin Exp Rheumatol; 1986; 4(1):53-6. PubMed ID: 3486076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement factor D in uremia.
    Sturfelt G; Truedsson L; Sjöholm A
    N Engl J Med; 1985 Jun; 312(24):1577. PubMed ID: 3846754
    [No Abstract]   [Full Text] [Related]  

  • 6. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
    Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
    Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in rheumatic diseases.
    Monteiro E; Ceboleiro C; Galvão-Teles A
    Lancet; 1979 Oct; 2(8146):797. PubMed ID: 90892
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenetics and rheumatic disease.
    Albert E; Scholz S
    Clin Exp Rheumatol; 1987; 5 Suppl 1():S29-34. PubMed ID: 3498596
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of the activity of the alternative pathway factor].
    Nakanishi I; Inai S
    Nihon Rinsho; 1979 Jun; Suppl():1451-3. PubMed ID: 490919
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocyte transformation to connective tissue antigens in adult and juvenile rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, systemic lupus erythematosus, and a nonarthritic control population.
    Golds EE; Stephen IB; Esdaile JM; Strawczynski H; Poole AR
    Cell Immunol; 1983 Nov; 82(1):196-209. PubMed ID: 6640674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients.
    Pamuk ÖN; Kalyoncu U; Aksu K; Omma A; Pehlivan Y; Çağatay Y; Küçükşahin O; Dönmez S; Çetin GY; Mercan R; Bayındır Ö; Çefle A; Yıldız F; Balkarlı A; Kılıç L; Çakır N; Kısacık B; Öksüz MF; Çobankara V; Onat AM; Sayarlıoğlu M; Öztürk MA; Pamuk GE; Akkoç N
    Rheumatol Int; 2016 Jul; 36(7):945-53. PubMed ID: 27221456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum C1q level does not predict joint erosion in early rheumatoid arthritis.
    Möttönen T; Hannonen P; Rautiainen J; Jokinen I; Oka M; Arvilommi H
    Arthritis Rheum; 1989 Apr; 32(4):511-2. PubMed ID: 2784969
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum C1q levels in rheumatoid arthritis.
    Parhami N; Rosano CL; Hurwitz C
    Arthritis Rheum; 1985 Feb; 28(2):240. PubMed ID: 3871619
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement factor D concentrations in normal sera: comparison of immunochemical and functional determinations.
    Sturfelt G; Truedsson L
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):383-9. PubMed ID: 6369875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of complement factor D in human serum by a solid-phase radioimmunoassay.
    Barnum SR; Niemann MA; Kearney JF; Volanakis JE
    J Immunol Methods; 1984 Mar; 67(2):303-9. PubMed ID: 6561229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and correlation between serum IgG and IgM antibodies to native type II collagen in patients with chronic inflammatory arthritis.
    Clague RB; Shaw MJ; Holt PJ
    Ann Rheum Dis; 1981 Feb; 40(1):6-10. PubMed ID: 7469526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian perspective on psoriasis, spondyloarthritis, rheumatoid arthritis and juvenile idiopathic arthritis: immunopathology and role of etanercept. Abstracts of a Seminars in Research. October 14-15, 2011. Italy.
    Clin Drug Investig; 2013 Aug; 33 Suppl 2():59-139. PubMed ID: 24404571
    [No Abstract]   [Full Text] [Related]  

  • 18. Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides.
    Chua-Aguilera CJ; Möller B; Yawalkar N
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):371-393. PubMed ID: 28752373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histocompatibility antigens and rheumatic diseases.
    Woodrow JC
    Semin Arthritis Rheum; 1977 Feb; 6(3):257-76. PubMed ID: 299958
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical significance of titered antinuclear antibodies.
    Ritchie RF
    Arthritis Rheum; 1967 Dec; 10(6):544-52. PubMed ID: 4864485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.